Skip to Main Content

Paper Details

Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15.
Blood Adv
9
2023
H929 MM cells, Human, IL-15, IL-15 receptor, MM, MM cell lines, MM cells, Multiple Myeloma, Multiple myeloma, NK, NK Cell, NK cells, NKTR-255, anti-CD38 antibody, circulating NK cells, humanized, mice, natural killer (NK) cell, patients, peripheral blood mononuclear cells, primary MM cells, tumor, tumor cell
Author NameAffiliation
Kenneth C AndersonThe LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School
Kenneth C AndersonThe LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School
  • 1 - 2

Datasets

Release 1.2